Clinical trial NCT04581304: The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.
Official title: The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Bone Loss
Missing Teeth
Lead sponsor: Rambam Health Care Campus
Sponsor class: OTHER
First posted: 2020-10-09
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: To assess vertical bone height gain with Geistlich Bio-Oss Collagen used in conjunction with simultaneous implant installation in transcrestal approach sinus augmentation.

Detailed description: One of the most common situations in the posterior maxilla is reduced alveolar bone height as a result of tooth extraction and the following bone remodeling process, and maxillary sinus pneumatization. Lack of alveolar bone volume may compromise dental implant installation. Maxillary sinus augmentation is considered a very predictable solution for implant installation in limited amount of bone in the posterior maxilla. In general, there are two main maxillary sinus augmentation methods: the lateral approach and the transcrestal. In both methods, the idea is to expend the alveolar ridge in vertical direction on the expense of the maxillary sinus. Sinus augmentation using the transcrestal approach is a well known procedure which is being use for over 40 years. As time goes by, implant dentistry is evolving and improving, there is a constant progress in this field including new bone substitutes materials.

Geistlich Bio-Oss® Collagen - can improve the results obtained by sinus augmentation using the transcrestal approach, by better ease of use for the operator which makes it easier for the operator and the patient.

Study hypothesis: The vertical bone height gained by using Geistlich Bio-Oss Collagen in transcrestal approach sinus augmentation will be comparable to using Bio-Oss Collagen, with greater operator satisfaction and less intra-operative complications.

Eligibility criteria: Inclusion Criteria:

* Patients above the age of 18.
* Patients with edentulous ridge maximal height of 8mm≥ beneath the maxillary sinus.
* Patients with edentulous ridge minimal height of 3mm≤ beneath the maxillary sinus.
* Patients who need single implant placement at the posterior maxilla.
* Signed, well filled and dated informed consent form.

Exclusion Criteria:

* Inability to complete or understand the informed consent process.
* Pregnant women.
* Lactating women.
* Patients who use medications that affect bone metabolism such as IV bisphosphonates.
* Heavy smokers.
* Patients with chronic/acute sinus infections

Primary outcomes:
measure: Vertical bone height. (mm) Changes in vertical bone height after transcrestal approach sinus augmentation.
timeFrame: Pre op; immediately post-op and at 6 months.
Secondary outcomes:
measure: The success rate of osseointegrated implants. (%)
timeFrame: At 6 months after intervention.
measure: Procedure time measurement. (min)
timeFrame: The procedure time measurement will start after flaps are elevated at pilot drilling (2.4mm diameter). and it will be stopped when the implant was inserted and insertion torque was assessed.
measure: Patients and operator satisfaction. (1-10 ruler scale)
timeFrame: At the suture removal visit - 14 days after procedure.
measure: Complications
timeFrame: During the procedure, During the follow up - 14 days, 6 months after intervention.
Other outcomes:
Locations:
city: Haifa
country: Israel
facility: Rambam Health Care Campus, Dept. of Periodontology
Study officials:
affiliation: Rambam Health Care Campus
name: Hadar Zigdon, DMD
role: PRINCIPAL_INVESTIGATOR
References: